首页|鲍曼不动杆菌相关耐药机制及新型治疗手段

鲍曼不动杆菌相关耐药机制及新型治疗手段

扫码查看
鲍曼不动杆菌在重症监护病房中是一种常见的多重耐药病原体,对危重患者构成显著威胁.面对有限的有效抗生素选择,鲍曼不动杆菌感染治疗面临诸多挑战,导致较高的感染率和死亡率.其耐药性归因于多种机制,包括外排泵作用、靶点突变、抗生素修饰酶的活化、生物膜形成及群体感应系统的调控.随着世界卫生组织将不动杆菌列为优先研发抗生素病原体,开发新抗生素的紧迫性显而易见.本文主要关注当前新型抗生素的开发、非传统抗菌药物的研究、潜在的疫苗以及多模式感染控制策略的推进.这些方法既是预防措施,也是应对抗生素耐药性不断升级挑战的替代治疗手段.
Mechanisms of Drug Resistance Associated with Acinetobacter baumannii and Treatment Progress
Acinetobacter baumannii,a prevalent multidrug-resistant pathogen in Intensive Care Units,poses a significant threat to critically ill patients.With limited effective antibiotic options,Acinetobacter baumannii infections lead to high infection and mortality rates.Its resistance mechanisms include efflux pump activity,target mutations,activation of antibiotic-modifying enzymes,biofilm formation,and quorum sensing system regulation.Recognizing Acinetobacter as a priority for antibiotic development,this article emphasized the urgency of developing new antibiotics.It concentrated on novel antibiotic development,exploring non-traditional antimicrobial agents,potential vaccines,and advancing multimodal infection control strategies,serving as both preventive and alternative therapeutic responses to the escalating challenge of antibiotic resistance.

Acinetobacter baumanniiDrug resistance mechanismMulti-mode sensing

史欣玥、张定宇

展开 >

华中科技大学同济医学院附属武汉金银潭医院,湖北省传染病临床医学研究中心,中国医学科学院武汉传染性疾病诊治研究中心,中国科学院武汉病毒研究所&武汉市金银潭医院感染性疾病与健康联合实验室(武汉 430023)

华中科技大学同济医学院附属协和医院重症医学科(武汉 430022)

鲍曼不动杆菌 耐药机制 多模式感控

2025

西南医科大学学报
泸州医学院

西南医科大学学报

影响因子:0.407
ISSN:2096-3351
年,卷(期):2025.48(1)